Transgene Biotek P/E Ratio
Transgene Biotek (TRABI) P/E ratio is not applicable — EPS (TTM) ₹-0.22, 8 consecutive loss quarters. See Healthcare Services peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company has been reporting losses for 8 consecutive quarters. P/E ratio cannot be calculated for loss-making companies.
Consecutive Loss Quarters: 8
Current EPS: ₹-0.22
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Mar 2026 | -0.06 | -1 | Loss |
| Jun 2026 | -0.05 | 0 | Loss |
| Sept 2025 | -0.05 | 0 | Loss |
| Mar 2025 | -0.09 | -1 | Loss |
| Jun 2025 | -0.06 | 0 | Loss |
| Dec 2025 | -0.05 | 0 | Loss |
| Sept 2024 | -0.01 | 0 | Loss |
| Mar 2024 | -0.04 | 0 | Loss |
Healthcare Services Peers with Valid P/E Ratios — TRABI Comparison
Healthcare Services sector average P/E 93.94, median 44.49 — TRABI excluded (negative EPS).
Sector Average PE
93.94
Sector Median PE
44.49
Lowest PE
7.19
Profitable Companies
58
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 7.19 | ₹135 | Low |
| Abate AS Industries | ABATEAS | 11.13 | ₹134 | Low |
| Deccan Health Care | DECCAN | 12.09 | ₹31 | Low |
| Nidan Labs & Healthcare | NIDAN | 12.27 | ₹19 | Low |
| One Global Service Provi… | ONEGLOBAL | 14.06 | ₹1,053 | Low |
| Shanmuga Hospital | SHANMUGA | 15.88 | ₹67 | Moderate |
| Invicta Diagnostic | INVICTA | 17.27 | ₹82 | Moderate |
| Indraprastha Medical Cor… | INDRAMEDCO | 17.69 | ₹3,355 | Moderate |
| Krsnaa Diagnostics | KRSNAA | 18.39 | ₹1,757 | Moderate |
| Chandan Healthcare | CHANDAN | 18.55 | ₹500 | Moderate |
Related Analysis
- For live price, revenue and the complete fundamental profile, see Transgene Biotek share price screener.
- Also explore TRABI stock price history to track price trends across different timeframes.